Brown Brothers Harriman & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.95M Buy
64,928
+10,783
+20% +$943K 0.03% 200
2026
Q1
$4.61M Buy
54,145
+8,937
+20% +$797K 0.02% 208
2025
Q4
$3.57M Buy
45,208
+5,698
+14% +$447K 0.02% 209
2025
Q3
$3.16M Sell
39,510
-962
-2% -$82.1K 0.02% 201
2025
Q2
$3.68M Sell
40,472
-2,380
-6% -$217K 0.02% 187
2025
Q1
$4.02M Sell
42,852
-1,423
-3% -$127K 0.03% 173
2024
Q4
$4.03M Sell
44,275
-3,946
-8% -$377K 0.03% 172
2024
Q3
$5.01M Sell
48,221
-2,060
-4% -$210K 0.03% 154
2024
Q2
$4.88M Sell
50,281
-1,732
-3% -$160K 0.04% 147
2024
Q1
$4.68M Sell
52,013
-3,537
-6% -$300K 0.04% 148
2023
Q4
$4.43M Sell
55,550
-9,366
-14% -$704K 0.04% 150
2023
Q3
$4.62M Sell
64,916
-15,511
-19% -$1.16M 0.04% 139
2023
Q2
$6.2M Sell
80,427
-12,799
-14% -$991K 0.05% 116
2023
Q1
$7.01M Sell
93,226
-3,443
-4% -$256K 0.06% 94
2022
Q4
$7.62M Sell
96,669
-25,100
-21% -$1.88M 0.07% 92
2022
Q3
$8.55M Sell
121,769
-36,064
-23% -$2.83M 0.08% 84
2022
Q2
$12.6M Sell
157,833
-38,493
-20% -$3.01M 0.11% 72
2022
Q1
$14.9M Sell
196,326
-2,956,063
-94% -$234M 0.11% 68
2021
Q4
$269M Buy
3,152,389
+19,035
+0.6% +$1.49M 1.51% 24
2021
Q3
$237M Buy
3,133,354
+110,301
+4% +$8.76M 1.4% 26
2021
Q2
$246M Sell
3,023,053
-49,062
-2% -$4.01M 1.45% 27
2021
Q1
$242M Sell
3,072,115
-452,398
-13% -$35.5M 1.54% 26
2020
Q4
$301M Sell
3,524,513
-165,913
-4% -$13.7M 2.01% 19
2020
Q3
$285M Sell
3,690,426
-245,964
-6% -$18.8M 2.04% 24
2020
Q2
$288M Sell
3,936,390
-147,716
-4% -$10.5M 2.17% 20
2020
Q1
$271M Buy
4,084,106
+81,681
+2% +$5.76M 2.21% 19
2019
Q4
$276M Buy
4,002,425
+693,729
+21% +$47.3M 1.76% 21
2019
Q3
$243M Sell
3,308,696
-88,001
-3% -$6.38M 1.63% 22
2019
Q2
$243M Sell
3,396,697
-22,905
-0.7% -$1.63M 1.62% 23
2019
Q1
$234M Buy
3,419,602
+3,329,873
+3,711% +$215M 1.62% 23
2018
Q4
$5.34M Buy
89,729
+4,050
+5% +$253K 0.04% 98
2018
Q3
$5.74M Buy
85,679
+1,684
+2% +$112K 0.04% 99
2018
Q2
$5.44M Sell
83,995
-1,222
-1% -$79.9K 0.03% 91
2018
Q1
$6.11M Sell
85,217
-3,936
-4% -$283K 0.04% 88
2017
Q4
$6.73M Sell
89,153
-737
-0.8% -$53.8K 0.04% 85
2017
Q3
$6.55M Sell
89,890
-295
-0.3% -$21.3K 0.03% 84
2017
Q2
$6.68M Sell
90,185
-1,000
-1% -$74.2K 0.04% 80
2017
Q1
$6.67M Sell
91,185
-420
-0.5% -$29.4K 0.04% 84
2016
Q4
$6M Buy
91,605
+430
+0.5% +$29.5K 0.03% 86
2016
Q3
$6.76M Sell
91,175
-14,503
-14% -$1.07M 0.04% 81
2016
Q2
$7.74M Sell
105,678
-296
-0.3% -$21.1K 0.04% 80
2016
Q1
$7.49M Sell
105,974
-2,550
-2% -$170K 0.04% 82
2015
Q4
$7.23M Sell
108,524
-6,482
-6% -$431K 0.04% 87
2015
Q3
$7.3M Sell
115,006
-8,735
-7% -$571K 0.04% 87
2015
Q2
$8.09M Sell
123,741
-4,051
-3% -$275K 0.04% 82
2015
Q1
$8.86M Sell
127,792
-4,360
-3% -$301K 0.04% 80
2014
Q4
$9.14M Buy
132,152
+12,735
+11% +$860K 0.04% 82
2014
Q3
$7.79M Sell
119,417
-3,070
-3% -$202K 0.03% 89
2014
Q2
$8.35M Sell
122,487
-3,730
-3% -$250K 0.03% 89
2014
Q1
$8.19M Sell
126,217
-152,987
-55% -$9.64M 0.04% 86
2013
Q4
$18.2M Buy
279,204
+139,426
+100% +$8.92M 0.04% 77
2013
Q3
$8.29M Buy
139,778
+11,820
+9% +$700K 0.04% 81
2013
Q2
$7.33M Buy
+127,958
New +$7.6M 0.03% 88

Other funds holding CL

Brown Brothers Harriman & Co's CL Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Colgate-Palmolive (CL) stake by 20% in Q2 2026, buying an estimated $943K and bringing the position to 64,928 shares worth $5.95M. The position accounts for 0.03% of the portfolio, ranked #200.

Brown Brothers Harriman & Co first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $301M in Q4 2020. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Brown Brothers Harriman & Co held 64,928 shares of Colgate-Palmolive worth $5.95M as of Q2 2026.
  • Brown Brothers Harriman & Co bought 10,783 Colgate-Palmolive shares in Q2 2026, an estimated $943K.
  • Colgate-Palmolive made up 0.03% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #200 holding.
  • Brown Brothers Harriman & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Brown Brothers Harriman & Co's Colgate-Palmolive position peaked at $301M in Q4 2020.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.